chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Severely tired around 7:45 pm and fell asleep. Woke up at 11:45 pm with a temperature. Around 5:00 am woke up with temperature and nausea. Extremely drowsy and weak, had someone drive me to work around 7:20 am (unable to call out). Sitting the entirety of the morning, around 12:15 pm was unable to hold self up, got to the ground to avoid passing out. Was pleased in a chair, uncontrollable shaking and was told I was incoherent, unable to hold myself up. My extremities were cold to the touch but my core was hot to the touch. They had me go to the floor since I was falling over, blood pressure was taken 90/60. Ambulance arrived on scene and took me to the hospital to get further evaluated since my blood pressure was till low, heart rate was high for laying down, and when having me stand up I wasn?t able to keep myself up. Ride to hospital they couldn?t get an IV in to give fluids since my BP cause my veins to ?shrink?. At the hospital they gave me ibuprofen and fluids when arriving. I stayed for several hours then being discharged stating I had a severe reaction to the moderna vaccine. For the next two days I?ve had severe fatigue.
approx 1 hr p/recvd vax onset high pitched crying lasting 2-3 days w/brief interruptions (about 15mins) to sleep; t103.8 R for approx 24 hrs;
Soreness around vaccinated area, next day and following- muscle ache under left arm pit area radiating to left chest muscle area. 21 Nov 02 area still sore not as bad, but still noticable
Post first vax, sometime thereafter pt experienced a dull heaviness in the affected arm. This resolved after one week. Post second vax, he experienced the same symptoms.
pt recv vax 15NOV96 & 3JUL97 pt exp chickenpox w/approx 20-30 blistered lesions;pt mom was in trimester of pregnancy @ that time; on 6JUL97 pt lesions were dried & pt recovered from exp;
This is a spontaneous report from a contactable Physician via Pfizer sales representative. A patient of unspecified age race/ethnicity and gender received TRUMENBA (Lot S85201, Expiration date Dec2019) via an unspecified route of administration on an unspecified date at 0.5 ml single for immunisation. The patient medical history and concomitant medications were not reported. The patient experienced hives on abdomine, arms, upper back, chest and upper legs (non-serious) on an unspecified date, one day after receiving the vaccination. The outcome of the event was unknown.
Systemic: see below for additional details-Medium, Additional Details: expired vial of Moderna Vaccine was given. Vaccine vial was punctured on May 30, 2021 and was not properly strong-pak'd out of system.
8/16/2023 - 8/17/2023 (27 hours) Date of Admission: 8/16/2023  Discharge Date:  08/17/2023 Discharge Disposition: Home or Self Care   past medical history of familial nonischemic cardiomyopathy since age 12, heart failure with reduced ejection fraction of 40% improved from 13%, colon polyp status post polypectomy in November of 2021, recent COVID-19 infection, recent negative stress test as an outpatient this past February, who presented with increasing shortness of breath and chest pain over the past 2 days prior to arrival.  4/17/2021 Moderna 037B21A 3/17/2021 Moderna 006B21A
Severe raised and hot rash on torso. Raised hard bump at site of shot all occurred two weeks after shot.
HA following #2 Moderna vaccine on 16FEB2021. Had fever, bodyache and arm pain which went away. Took 2tabs of 325mg tylenol which is not helpful.
Patient received his rotavirus vaccine on Friday (6/2/23). Sunday (6/4/23) patient was notably more tired. Monday AM (6/5/23) patient began to have persistent episodes of crying, two episodes of projectile vomiting, bloody stools, and periods of decreased responsiveness. Parents brought patient to pediatrician for evaluation. Pediatrician drew bloodwork and sent Pt to Emergency Room where Pt was found to have left-lower quadrant intussusception on Ultrasound. Air enema reduction performed, but there was concern for incomplete reduction on follow-up imaging. Pt was then taken for diagnostic laparoscopy with no intussusception found,  bowel found to be mildly edematous, but no lead point identified or any cystic structure (had been concern for possible cystic lead point on previous US).
This was my second shot.  With the first I had sore arm for 2 days and joint point at left hip.  A few days prior to second shot i developed irritation on 2 days of left foot.  Following second shot, I had sore arm for a day and a half, joint pain at left hip that extended all the way down my leg which caused difficulty walking.  That pain lasted for 2 full days.  The toe irritation developed into painful blisters and extended to 3 toes on my left foot.  I am currently using Hydro cortisone cream on them.
Dizziness, Headache, Myalgia, Fever, Photophobia Narrative:  Dizzy/Headache. Waited and hour. Returned to office. Wed AM. Head killing her. Less severe local pain. Bocy aches Wearing sunglasses & closing blinds in house all day. Slept half of the morning. Fever 100.8 all day. Th AM HA and worse body aches. HA improving. No sunglasses. Body aches still bad. No N
Conjunctivitis (bilateral) beginning directly after shot and slowly progressing over 24-48 hours; This is a spontaneous report from a contactable Physician. This physician reported for a 12-year-old female patient (reporter's daughter) .A 12-year-old female patient received bnt162b2 (BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection), DOSE 2 intramuscular on 06Jun2021 at 12:30 into arm left (Lot Number:EW0179 ) as DOSE 2, SINGLE (at age of 12 years) and received DOSE 1 intramuscular on 16May2021 at 12:30 into arm left (Lot Number: EW0177 as DOSE 1, SINGLE for covid-19 immunization (at age of 12 years) at school or student health clinic. The patient medical history had included ongoing anxiety and concomitant medication included included Ergocalciferol(vitamin D) and fish oil for unknown indication. Concomitant therapy included ongoing oral Deptlin for Anxiety. It was reported that patient was not pregnant at the time of vaccination. The patient did not take any vaccination within four weeks. The patient had no known allergies. The patient did not experienced Covid prior to vaccination and did not underwent from any Covid-19 test after vaccination. On 16may2021 at 01:00 the patient had experienced  bilateral conjunctivitis irritation within 15minutes of 1st vaccine. Improved within 72 hours and recovered shortly after 2nd vaccine but was less intense and shorter in duration. It was reported that after second dose on 06Jun2021 at 01:00, patient also experienced Conjunctivitis. Therapeutic measures were taken for the AE and treatment was given with Benadryl orally and Cat scan, X-ray, MRI as reported. Seriousness criteria was reported as not serious. The clinical outcome of the event was recovered.  Follow-up attempts are completed. No further information is expected.
Redness, swelling, and itchiness at site of injection. Redness is about 3.5cm in diameter and swelling about 4cm in diameter.
16SEP 4-5 hrs following vax legs did not want to move devel general fatigue (lasted 3 wks); In the next 2 day devel addtl sx of aching in both hips & lt knee; radiating pain form both hips & lt knee; limping  w/dec endurance;
Pt was given Pfizer Covid booster dose on 9/1/22 and the recommendations had changed on 8/31/22 to use Bivalent boosters going forward.  Pharmacy was not aware of the changes that had gone in place yet and did not have the Bivalent Booster in stock.
Pt mom states pt developed a localized area of swelling and redness that was still present when pt was brought in for evaluation on 03/22/2012.
Patient was transferred to ED on 8/7/21 from rehab after cardiac arrest and then transferred to ICU at another facility. Arrest was thought to be most likely due to hypoxia iso respiratory failure from ADCHF and superimposed covid infection. Patient is fully vaccinated. Patient tested positive for covid on 8/5 but imaging not consistent with covid pneumonia. Respiratory failure largely driven by large bilateral pleural effusion and pulmonary edema secondary to decompensated heart failure. Remdesivir was deferred due to renal and hepatic impairment. Patient was pronounced deceased on 8/11 after family elected to decline further intervention and transition to CMO only on 8/10.
increased blood pressure/blood pressure elevated; itchiness; left arm sore/stiff; slight headache; This is a spontaneous report from a contactable consumer (patient). A 48-years-old female received first dose of BNT162b2 (PFIZER-BIONTEC COVID-19 VACCINE, Solution for injection, Lot Number: E13249) via intramuscularly in the left arm on 05Feb2021 at around 11:00 or 11:15 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included severe sinusitis diagnosed about a year ago. she had surgery for this in Dec2019. Concomitant medication was not reported. No additional vaccines administered on same date of suspect. No prior Vaccinations within 4 weeks. No events following prior vaccinations. On 05Feb2021 (on day of vaccination), patient had slight headache, itchiness and left arm sore/stiff. On 10Feb2021 (5 days after vaccination), patient had increased blood pressure/blood pressure elevated. She had itchiness and then a slight headache and it went away. Her left arm was sore and hurt for about 48 hours and then it went away. She has been feeling fine. Today she suddenly had a really bad headache. She took her blood pressure and it was really elevated. She was asking if this was from the vaccine. Reports the itchiness recovered within an hour. Her sore arm did not start till several hours after receiving the injection, did not feel it at first and wondered if she had even received the injection. Then that evening her arm was stiff and sore which recovered by sunday morning. She was wondering if she should go and get herself checked out and not sure if it was from the vaccine. She has not checked her blood pressure since she has been on hold. This morning when she checked her blood pressure it was elevated for her at 160/100. Then she checked it a few minutes later and it was 170/98, she wanted to make sure it was not in her head and rechecked it again and it was 175/101. No treatment was received. Events does not require a visit to emergency room and physician office. Lab test included blood pressure on 10Feb2021, was 160/100, 170/98 and 175/101. The outcome for event itchiness was resolved on 05Feb2021, left arm sore/stiff was resolved on 07Feb2021, headache resolved on 10Feb2021 and unknown for increased blood pressure/blood pressure elevated.  Follow-up attempts completed. No further information expected.
COVID19; COVID19;   This is a solicited report received from contactable reporter(s) (Consumer or other non HCP) for a sponsored program. The reporter is the patient. Other Case identifier(s): 21K-163-4192024-00.  A 29-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), intramuscular, administration date 21Apr2021 (Batch/Lot number: unknown) at the age of 29 years, as dose 2, single and intramuscular, administration date 31Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation; adalimumab (HUMIRA), subcutaneous (Batch/Lot number: unknown) citrate free (as reported) for rheumatoid arthritis, psoriasis. The patient's relevant medical history and concomitant medications were not reported. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Apr2021, outcome "recovered" (2021) and all described as "COVID19". The action taken for adalimumab was unknown. The patient received BNT162b2 booster dose intramuscular in 2021 for COVID-19 Vaccination.  The reporter considered there was a reasonable possibility that the Covid-19 was related to bnt162b2. The reporter did not provide causality for adalimumab and event Covid-19.  The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: Based on the information currently available, a lack of efficacy with the suspected vaccine bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) in this patient cannot be excluded.  Further information like specific COVID infection date needed for a full medical assessment.,Linked Report(s) : PFIZER INC-202101780508 same patient, different vaccine dose
pt recvd vax 2FEB93 approx 2 1/2-3 hrs p/immun, pt began crying inconsolably, crying cont for 2 1/2 hrs; seen by MD: pt was given APAP immed p/immun; pt recovered;
pt recvd vax & devel fever to 105, chills & grand mal sz;
VENOUS THROMBOSIS; PAIN IN LEFT LEG; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 06-APR-2021 for prophylactic vaccination. Frequency was 1 total. Vaccination site was unspecified. No concomitant medications were reported.  Batch number is not reported and has been requested. On 09-APR-2021, the patient experienced pain in left leg. On 16-APR-2021, he was diagnosed venous thrombosis, and  he was hospitalized (date unspecified). Consumer told that currently patient was admitted when she called. Treatment to treat adverse event was not reported. Hospital name and address was not reported. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from venous thrombosis, and pain in left leg. This report was serious (Hospitalization Caused / Prolonged, and Other Medically Important Condition).; Sender's Comments: V0:  This is a spontaneous report of a male of unspecified age who developed a venous thrombosis and was hospitalized 10 days after receiving the Janssen COVID-19 vaccine.  No medical history, concomitant medications or additional details were reported.  Additional information has been requested.  The case will be assessed further when additional information is received.
Numbing of left side of face. Started approx 4 hours after injection and still slightly present 3 days later; This is a spontaneous report from a contactable consumer or other non hcp. A 44-years-old non-pregnant female patient received first dose bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EN6206) via an unspecified route of administration, in Arm Left on 07Mar2021 08:45 (age at vaccination:44-years-old) as DOSE 1, SINGLE for covid-19 immunisation. Patient didn't receive other vaccines within 4 weeks prior to vaccination. The patient medical history and concomitant medications were not reported patient had no allergies patient didn't had covid prior to vaccination, patient was not tested for covid to post vaccination. The patient experienced numbing of left side of face. started approx. 4 hours after injection and still slightly present 3 days later on 07Mar2021 12:30. Therapeutic measures were taken as a result of numbing of left side of face. started approx 4 hours after injection and still slightly present 3 days later. The outcome of the event hypoaesthesia was not recovered.  No follow up attempts are possible. No further information is expected.
Information has been received from a physician concerning his 71 year old wife who "about 5 weeks ago" approximately 28-JAN-2008 was vaccinated SQ with ZOSTAVAX (Oka/Merck).  There was no concomitant medication.  On the day after receiving ZOSTAVAX (Oka/Merck) the patient developed vertigo.  Unspecified medical attention was sought.  There were no lab studies performed.  At the time of the report the patient was recovering.  Her husband stated his wife's vertigo seemed to improve slightly with exercise.  There was no product quality complaint involved.  Follow-up information from the 71 year old white female patient with multiple airborne allergies indicated that on 05-FEB-2008 she was vaccinated "mid-day" in the upper right arm with ZOSTAVAX (Oka/Merck).  There was no illness at the time of vaccination.  Subsequently, on 06-Feb-2008 she had a whirling sensation when she laid down, rolled over or sat up.  On an unspecified date she had a chiropractic evaluation to see if her neck was out of place, which it was not.  The chiropractor adjusted her lower back primarily.  After the chiropractic adjustment (that did not include her neck) she nearly fell over, but her doctor caught her.  On 06-MAR-2008 the patient recovered.  It was noted that the patient had made an ENT appointment by phone before the vertigo subsided.  The patient stated she saw the doctor after 06-MAR-2008 so he only explained things to her.  The doctor's explanation of the condition was Benign Positional Vertigo.  The patient considered her vertigo to be disabling.  Additional information is not expected.
Vaccine administered on 9/30/14 - vomiting is hot and cold flashes next morning - then noticed arm sore then would not move (hard to move) (stiff).
1st booster shot was 100 µg, not 50; This spontaneous case was reported by a consumer and describes the occurrence of ACCIDENTAL OVERDOSE (1st booster shot was 100 µg, not 50) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 100 microgram. On an unknown date, the patient experienced ACCIDENTAL OVERDOSE (1st booster shot was 100 µg, not 50). At the time of the report, ACCIDENTAL OVERDOSE (1st booster shot was 100 µg, not 50) outcome was unknown.            No concomitant product use was provided. No treatment medication was provided.
left hand pinky finger and ring finger tingling and ache/pain all day; left hand pinky finger and ring finger tingling and ache/pain all day; site injection and shoulder pain in left arm; This is a spontaneous case received from a contactable consumer (patient herself). A 42-year-old female patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EL3247, Expiration date: May2021), via an unspecified route of administration, administered on 02Mar2021 as DOSE 1, SINGLE (age at vaccination 42-year-old) for COVID-19 immunization. The patient medical history included allergies to steroids, allergy/contact dermatitis from latex, allergy/sensitivity to dairy, diagnosed with eczema in teens and with IBS (irritable bowel syndrome) in 2018. Concomitant medications were reported as none. On 02Mar2021, the patient experienced site injection and shoulder pain in left arm. On 03Mar2021, the patient experienced left hand pinky finger and ring finger tingling and ache/pain all day. The outcome of the event on was recovering (04Mar2021 symptoms subsiding). No follow-up attempts are possible. No further information is expected.
Patient pulled away from vaccine before the entire dose was administered.  It is unknown how much of the first dose she received.  No adverse reaction from the patient after monitoring.  Patient was advised to come back on Apr 18 for her 2nd Pfizer dose.  No additional prime vaccine was administered after event.
Dizziness, nausea, paleness, chills, dark spots in vision. Water, cool packs to head/neck, sitting position.
Major swelling of right arm, hot to touch, painful to touch. Visited primary care who gave Rx for prednisone x 5 days and clindamycin 300 mg. Cleared up in following days.
Patient was administered Janssen COVID vaccine. Patient was fine immediately post administration in the IMZ room but witness stated he fell sideways (within a few minutes of receiving the vaccine) out of post-administration observation chair (which is in front of the pharmacy). Technician called code white and patient was immediately met with management and the pharmacy team. Patient was laying on his stomach on the floor, supporting himself upward with both hands/forearms. Patient had blood dripping from forehead and nose. Gauze was applied to laceration on forehead to help with bleeding and once patient was able to roll over on his back, an ice pack was applied to his forehead/nose area. Patient said he felt "pain" after the injection and then he felt light-headed. He remembered blacking out for a few seconds. Patient stated he felt "ok", then later stated he felt better but just had a bad headache. Patient stated he felt "it starting to hurt" and that it triggered his anxiety. Dad was in the store and arrived a few minutes later; dad said son/patient has a "fear of needles" and "he hasn't had anything to eat today in quite awhile". EMS arrived to examine patient and asked him if he needed to go to the ER; dad felt going to the ER was for the best since they had a 3 hour car ride home. Paramedics then transported patient to the ER and said he would likely need a stitch for the cut above his eyebrow.
This spontaneous report was received from an office manager, referring to multiple unspecified patients of unknown age and gender. Information regarding the patients' medical history, concurrent conditions and concomitant medication were not reported. On unspecified dates, patients were administered doses of improperly stored VAQTA (lot # M009377, expiration date on 17-JUN-2017/lot # M011839, expiration date on 13-SEP-2017). It was reported that the vaccine was exposed for 22 hours at 30.9 F degrees. No adverse effects were reported. This is one of the several reports received from the same reporter. Additional information has been requested.
Dose was administered beyond 12 hour mark.  Vial initial  punctured on 01/03/2022; refrigerated, and dose administered from same vial to patient on 1/4/22 2:45pm.
patient developed an extremely itchy rash all over her body and was prescribed prednisone to treat
Patient received 1st shot of Pfizer Covid vaccine approximately 3-5 minutes later patient complains of feeling dizzy then it felt like her throat was swelling and she couldn't breath. She then fainted while sitting and slumped onto the floor. Epipen was admistered but was only able to hold for 2 secs due to patient complaining about the epipen shot hurting and kicked her legs dislodging epipen from leg. When patient came to she was not aware how she got onto the floor.  Patient was awake when EMT arrived to transport patient to nearest hospital however was not all there due to having to think what her birthday was when EMT asked.
Patient stated that the left side of her shoulder blade. It is up by her neck. It is tender to the touch, It feels like there is a knot in the middle.
Client presented at Public Health office in the afternoon on 9-23-2010 with a large area on her left arm red, swollen and warm to the touch.  In approximately the area that the MMR had been administered, there was a blister measuring 30mm x 20mm.  The client reported a low grade fever the previous evening, but did not check her temp with a thermometer.  No fever present when client presented to PH.  Client was taking OTC meds for discomfort that day.  Client reported first noticing the blister in the evening of 9-22-10.  Although the blister was large, she had not noticed it until she was changing her clothes for the day due to its location on the back of her arm.